Predictive Factors for Target Organ Injuries in Hypertensive Individuals

References

• Cameron AC, Lang NN, Touyz RM. Drug treatment of hypertension: focus on vascular health. Drugs. 2016;76(16):1529–1550. doi:10.1007/s40265-016-0642-8
   PubMed Web of Science ®Google Scholar
• Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. JAMA. 2016;315(24):2673–2682. doi:10.1001/jama.2016.7050
   PubMed Web of Science ®Google Scholar
• Malachias MVB, Gomes MAM, Nobre F, Alessi A, Feitosa AD, Coelho EB. 7th Brazilian guideline on hypertension. Arq Bras Cardiol. 2016;107(3Supl.3):7–13. doi:10.5935/abc.20160152
   Web of Science ®Google Scholar
• Vernooij JW, van der Graaf Y, Nathoe HM, Bemelmans RH, Visseren FL, Spiering W. Hypertensive target organ damage and the risk for vascular and all-cause mortality in patients with vascular disease. J Hypertens. 2013;31(3):492–499. doi:10.1097/HJH.0b013e32835cd3cd
   PubMed Web of Science ®Google Scholar
• Wright JT, Williamson JD, Whelton PK, et al.; The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103–2116. doi:10.1056/NEJMoa1511939.
   PubMed Web of Science ®Google Scholar
• Mancia G, Verdecchia P, Boehme AK, Esenwa C. Clinical value of ambulatory blood pressure: evidence and limits. Circ Res. 2015;116(6):1034–1045. doi:10.1161/CIRCRESAHA.116.303755
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension - the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021–3104. doi:10.1093/eurheartj/ehy339
   PubMed Web of Science ®Google Scholar
• Sebba Barroso WK, Rodrigues CIS, Bortolotto LA, et al. Brazilian Guidelines of Hypertension – 2020. Arq Bras Cardiol. 2021;116(3):516–658. doi:10.36660/abc.20201238
   Web of Science ®Google Scholar
• Brazilian Diabetes Society Guidelines: 2019–2020 [homepage on the Internet]. Available from: https://www.diabetes.org.br/profissional/images/DIRETRIZES-COMPLETA-2019-2020.pdf. Accessed April 05, 2021.
   Google Scholar
• Barbosa MM, Nunes MCP, Campos Filho O, et al. Brazilian Society of Cardiology. Guidelines for echocardiography indications. Arq Bras Cardiol. 2009;93(6suppl.3):e265–e302.
   Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39.e14. doi:10.1016/j.echo.2014.10.003
   PubMed Web of Science ®Google Scholar
• Rosenthal RL. The 50% coronary stenosis. Am J Cardiol. 2015;115(8):1162–1165. doi:10.1016/j.amjcard.2015.01.553
   PubMed Web of Science ®Google Scholar
• Neglia D, Rovai D, Caselli C, et al.; EVINCI Study Investigators. Detection of significant coronary artery disease by noninvasive anatomical and functional imaging. Circ Cardiovasc Imaging. 2015;8(3):e002179. doi:10.1161/CIRCIMAGING.114.002179.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al.; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Bronner LL, Kanter DS, Manson JE. Primary prevention of stroke. N Engl J Med. 1995;333(21):1392–1400. doi:10.1056/NEJM199511233332106
   PubMed Web of Science ®Google Scholar
• He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J. 1999;138(3):211–219. doi:10.1016/s0002-8703(99)70312-1
   Web of Science ®Google Scholar
• Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387(10017):435–443. doi:10.1016/S0140-6736(15)00805-3
   PubMed Web of Science ®Google Scholar
• Yusuf S, Teo KK, Pogue J, et al.; The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358(15):1547–1559. doi:10.1056/NEJMoa0801317.
   PubMed Web of Science ®Google Scholar
• Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension: systolic hypertension in the Elderly Program Cooperative Research Group. JAMA. 1996;276(23):1886–1892. doi:10.1001/jama.1996.03540230036032
   PubMed Web of Science ®Google Scholar
• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981–2997. doi:10.1001/jama.288.23.2981.
   PubMed Web of Science ®Google Scholar
• Clement DL, Buyzere ML, Bacquer DA, et al.; Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–2415. doi:10.1056/NEJMoa022273
   PubMed Web of Science ®Google Scholar
• Bliziotis IA, Destounis A, Stergiou GS. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30(7):1289–1299. doi:10.1097/HJH.0b013e3283531eaf
   PubMed Web of Science ®Google Scholar
• Yildiz M, Oktay AA, Stewart MH, Milani RV, Ventura HO, Lavie CJ. Left ventricular hypertrophy and hypertension. Prog Cardiovasc Dis. 2020;63(1):10–21. doi:10.1016/j.pcad.2019.11.009
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Sala C, Negri F, Mancia G, Morganti A. Italian Society of Hypertension. Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens. 2012;26(6):343–349. doi:10.1038/jhh.2011.104
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang H, Huynh Q, et al. Diagnosis of nonischemic stage B heart failure in type 2 diabetes mellitus: optimal parameters for prediction of heart failure. JACC Cardiovasc Imaging. 2018;11(10):1390–1400. doi:10.1016/j.jcmg.2018.03.015
   Web of Science ®Google Scholar
• Brunström M, Carlberg B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(1):28–36. doi:10.1001/jamainternmed.2017.6015
   PubMed Web of Science ®Google Scholar
• Guang H, Wang X, Treiber F, Harshfield G, Kapuku G, Su S. Blood pressure trajectories, carotid artery intima-media thickness and left ventricular mass: results from a 23-year longitudinal study from childhood to young adulthood. Circulation. 2016;134:A18729.
   Web of Science ®Google Scholar
• Verdecchia P, Schillaci G, Guerrieri M, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation. 1990;81:528–536. doi:10.1161/01.CIR.81.2.528
   PubMed Web of Science ®Google Scholar
• Palatini P, Penzo M, Racioppa A, et al. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med. 1992;152:1855–1860. doi:10.1001/archinte.1992.00400210081013
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Ambrosius WT, Cushman WC, et al.; SPRINT Research Study Group. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: SPRINT (Systolic Blood Pressure Intervention Trial). Circulation. 2017;136(5):440–450. doi:10.1161/CIRCULATIONAHA.117.028441.
   PubMed Web of Science ®Google Scholar
• Skali H, Shah A, Gupta DK, et al. Cardiac structure and function across the glycemic spectrum in elderly men and women free of prevalent heart disease: the atherosclerosis risk in the community study. Circ Heart Fail. 2015;8(3):448–454. doi:10.1161/CIRCHEARTFAILURE.114.001990
   PubMed Web of Science ®Google Scholar
• Iwakura K. Heart failure in patients with type 2 diabetes mellitus: assessment with echocardiography and effects of antihyperglycemic treatments. J Echocardiogr. 2019;17(4):177–186. doi:10.1007/s12574-019-00446-9
   Web of Science ®Google Scholar
• Bang CN, Soliman EZ, Simpson LM, et al.; ALLHAT Collaborative Research Group. Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: the ALLHAT study. Am J Hypertens. 2017;30(9):914–922. doi:10.1093/ajh/hpx067.
   PubMed Web of Science ®Google Scholar
• Cao X, Broughton ST, Waits GS, Nguyen T, Li Y, Soliman EZ. Interrelations between hypertension and electrocardiographic left ventricular hypertrophy and their associations with cardiovascular mortality. Am J Cardiol. 2019;123(2):274–283. doi:10.1016/j.amjcard.2018.10.006
   PubMed Web of Science ®Google Scholar
• Bardini G, Innocenti M, Rotella CM, Giannini S, Mannucci E. Variability of triglyceride levels and incidence of microalbuminuria in type 2 diabetes. J Clin Lipidol. 2016;10(1):109–115. doi:10.1016/j.jacl.2015.10.001
   Web of Science ®Google Scholar
• Xie Q, Xu C, Wan Q. Association between microalbuminuria and outcome of non-diabetic population aged 40 years and over: the reaction study. Prim Diabetes Care. 2020;14(4):376–380. doi:10.1016/j.pcd.2019.12.003
   Web of Science ®Google Scholar
• Cao Y, Sun G, Liu R, et al. Plasma triglyceride levels and central obesity predict the development of kidney injury in Chinese community older adults. Ren Fail. 2019;41(1):946–953. doi:10.1080/0886022X.2019.1655451
   PubMed Web of Science ®Google Scholar
• Huang F, Wang L, Zhang Q, et al. Elevated atherogenic index and higher triglyceride increase risk of kidney function decline: a 7-year cohort study in Chinese adults. Ren Fail. 2021;43(1):32–39. doi:10.1080/0886022X.2020.1853569
   PubMed Web of Science ®Google Scholar
• Showail AA, Ghoraba M. The association between glycemic control and microalbuminuria in type 2 diabetes. Saudi J Kidney Transpl. 2016;27(3):473–479. doi:10.4103/1319-2442.182379
   Google Scholar
• Shen Y, Shi L, Nauman E, et al. Inverse association between HDL (High-Density Lipoprotein) cholesterol and stroke risk among patients with type 2 diabetes mellitus. Stroke. 2019;50(2):291–297. doi:10.1161/STROKEAHA.118.023682
   Web of Science ®Google Scholar
• Watanabe J, Kakehi E, Kotani K, Kayaba K, Nakamura Y, Ishikawa S. Isolated low levels of high-density lipoprotein cholesterol and stroke incidence: JMS Cohort Study. J Clin Lab Anal. 2020;34:e23087. doi:10.1002/jcla.23087
   Web of Science ®Google Scholar
• Hitman GA, Colhoun H, Newman C, et al.; CARDS Investigators. Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabet Med. 24;2007;1313–1321. doi:10.1111/j.1464-5491.2007.02268.x
   PubMed Web of Science ®Google Scholar
• Leitão L, Soares-dos-Reis R, Neves JS, Baptista RB, Vieira MB, Causland FR. Intensive blood pressure treatment reduced stroke risk in patients with albuminuria in the SPRINT trial. Stroke. 2019;50:3639–3642. doi:10.1161/STROKEAHA.119.026316
   PubMed Web of Science ®Google Scholar
• Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–2236. doi:10.1161/STR.0000000000000024
   PubMed Web of Science ®Google Scholar
• Boehme AK, Esenwa C, Elkind MSV. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120:472–495. doi:10.1161/CIRCRESAHA.116.308398
   PubMed Web of Science ®Google Scholar
• McEvoy JW, Daya N, Rahman F, et al. Association of isolated diastolic hypertension as defined by the 2017 ACC/AHA blood pressure guideline with incident cardiovascular outcomes. JAMA. 2020;323(4):329–338. doi:10.1001/jama.2019.21402
   PubMed Web of Science ®Google Scholar
• Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the cardiovascular prospective Münster (PROCAM) study. Circulation. 2002;105(3):310–315. doi:10.1161/hc0302.102575
   PubMed Web of Science ®Google Scholar
• D’Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579
   PubMed Web of Science ®Google Scholar
• Malta DC, Pinheiro PC, Teixeira RA, Machado IE, Santos FM, Ribeiro ALP. Estimates of ten-year cardiovascular risk in the Brazilian population: a population-based study. Arq Bras Cardiol. 2021;116(3):423–431. doi:10.36660/abc.20190861
   Web of Science ®Google Scholar